PL3022215T3 - Stabilizowana postać Tetrofosminy i jej zastosowanie - Google Patents
Stabilizowana postać Tetrofosminy i jej zastosowanieInfo
- Publication number
- PL3022215T3 PL3022215T3 PL15703024T PL15703024T PL3022215T3 PL 3022215 T3 PL3022215 T3 PL 3022215T3 PL 15703024 T PL15703024 T PL 15703024T PL 15703024 T PL15703024 T PL 15703024T PL 3022215 T3 PL3022215 T3 PL 3022215T3
- Authority
- PL
- Poland
- Prior art keywords
- tetrofosmin
- stabilized form
- stabilized
- Prior art date
Links
- QCWJONLQSHEGEJ-UHFFFAOYSA-N tetrofosmin Chemical compound CCOCCP(CCOCC)CCP(CCOCC)CCOCC QCWJONLQSHEGEJ-UHFFFAOYSA-N 0.000 title 1
- 229960004113 tetrofosmin Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/50—Organo-phosphines
- C07F9/5027—Polyphosphines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
- C07F13/005—Compounds without a metal-carbon linkage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/50—Organo-phosphines
- C07F9/505—Preparation; Separation; Purification; Stabilisation
- C07F9/5095—Separation; Purification; Stabilisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/54—Quaternary phosphonium compounds
- C07F9/5449—Polyphosphonium compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14152885.1A EP2899195A1 (en) | 2014-01-28 | 2014-01-28 | Stabilized form of Tetrofosmin and its use |
| EP15703024.8A EP3022215B1 (en) | 2014-01-28 | 2015-01-28 | Stabilized form of tetrofosmin and its use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3022215T3 true PL3022215T3 (pl) | 2017-07-31 |
Family
ID=50068797
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15703024T PL3022215T3 (pl) | 2014-01-28 | 2015-01-28 | Stabilizowana postać Tetrofosminy i jej zastosowanie |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US9963473B2 (pl) |
| EP (2) | EP2899195A1 (pl) |
| AU (1) | AU2015212915B2 (pl) |
| CA (1) | CA2936884C (pl) |
| ES (1) | ES2616045T3 (pl) |
| HU (1) | HUE031983T2 (pl) |
| PL (1) | PL3022215T3 (pl) |
| WO (1) | WO2015114002A1 (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10460227B2 (en) | 2015-05-15 | 2019-10-29 | Apple Inc. | Virtual assistant in a communication session |
| KR20190128545A (ko) | 2017-03-08 | 2019-11-18 | 주빌런트 제네릭스 리미티드(포멀리 어 디비젼 오브 주빌런트 라이프 사이언시스 리미티드) | 테트로포스민 또는 그것의 산 부가 염의 제조를 위한 개선된 과정 |
| BR112020005243A2 (pt) * | 2017-11-23 | 2020-09-24 | Jubilant Generics Limited (Formerly A Division Of Jubilant Life Sciences Limited) | composição farmacêutica compreendendo tetrofosmina e sais farmaceuticamente aceitáveis da mesma |
| US12230264B2 (en) | 2021-08-13 | 2025-02-18 | Apple Inc. | Digital assistant interaction in a communication session |
| CN114702522A (zh) * | 2022-04-12 | 2022-07-05 | 无锡市江原实业技贸有限公司 | 一种双乙氧乙膦烷的制备方法及反应装置 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8723438D0 (en) | 1987-10-06 | 1987-11-11 | Amersham Int Plc | Cationic complexes of technetium-99m |
| GB8808414D0 (en) | 1988-04-11 | 1988-05-11 | Amersham Int Plc | Ligands & cationic complexes thereof with technetium-99m |
| CN1184225C (zh) | 2000-06-28 | 2005-01-12 | 北京师范大学 | 一种替曲膦季鏻盐及其制法和二步法替曲膦药盒及其应用 |
| GB0031592D0 (en) | 2000-12-28 | 2001-02-07 | Nycomed Amersham Plc | Stabilised radiopharmaceutical compositions |
| DE102005005446A1 (de) * | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Bruchfeste Darreichungsformen mit retardierter Freisetzung |
| GB0427392D0 (en) | 2004-12-15 | 2005-01-19 | Amersham Plc | Stabilised 99mTc compositions |
| WO2007148088A2 (en) | 2006-06-21 | 2007-12-27 | Ge Healthcare Limited | Radiopharmaceutical products |
| EP1894938A1 (en) * | 2006-08-31 | 2008-03-05 | Evonik Degussa GmbH | New cyclopentadienyl, indenyl or fluorenyl substituted phosphine compounds and their use in catalytic reactions |
| GB0718386D0 (en) | 2007-09-21 | 2007-10-31 | Ge Healthcare As | Improved radiopharmaceutical formulation |
| US20110319636A1 (en) * | 2008-11-24 | 2011-12-29 | Technical University Of Denmark | Method for preparation of amides from alcohols and amines by extrusion of hydrogen |
| US8207364B2 (en) * | 2009-05-26 | 2012-06-26 | Johnson Matthey Public Limited Company | Process for preparing a complex |
| US9365596B2 (en) * | 2013-12-13 | 2016-06-14 | Microvast Power Systems Co., Ltd. | Method for preparing quaternary phosphonium salts |
-
2014
- 2014-01-28 EP EP14152885.1A patent/EP2899195A1/en not_active Withdrawn
-
2015
- 2015-01-28 US US15/114,658 patent/US9963473B2/en active Active
- 2015-01-28 HU HUE15703024A patent/HUE031983T2/en unknown
- 2015-01-28 PL PL15703024T patent/PL3022215T3/pl unknown
- 2015-01-28 AU AU2015212915A patent/AU2015212915B2/en not_active Ceased
- 2015-01-28 CA CA2936884A patent/CA2936884C/en active Active
- 2015-01-28 ES ES15703024.8T patent/ES2616045T3/es active Active
- 2015-01-28 WO PCT/EP2015/051699 patent/WO2015114002A1/en not_active Ceased
- 2015-01-28 EP EP15703024.8A patent/EP3022215B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US9963473B2 (en) | 2018-05-08 |
| EP3022215A1 (en) | 2016-05-25 |
| AU2015212915A1 (en) | 2016-08-04 |
| WO2015114002A1 (en) | 2015-08-06 |
| EP3022215B1 (en) | 2016-12-07 |
| US20160355532A1 (en) | 2016-12-08 |
| ES2616045T3 (es) | 2017-06-09 |
| CA2936884C (en) | 2017-05-23 |
| EP2899195A1 (en) | 2015-07-29 |
| HUE031983T2 (en) | 2017-08-28 |
| CA2936884A1 (en) | 2015-08-06 |
| AU2015212915B2 (en) | 2016-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL250415B (en) | Antibodies against pd-l and methods of using them | |
| IL252216A0 (en) | Difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidines | |
| HUE061672T2 (hu) | Glikán-interakcióban lévõ vegyületek és felhasználási módszerek | |
| IL247014A0 (en) | 6-heteroaryloxy and 6-aryloxy-quinoline-2-carboxamides and their use | |
| GB201421847D0 (en) | Dispensers and methods of use thereof | |
| GB201411197D0 (en) | Composition and use thereof | |
| HUE060941T2 (hu) | Halogénolefin-bázisú készítmény és alkalmazása | |
| HUE044571T2 (hu) | Módosított ciklopentapeptidek és alkalmazásaik | |
| PT3089971T (pt) | Compostos e métodos de utilização | |
| IL282482A (en) | Variants of protoxin-II and methods of use | |
| GB201401617D0 (en) | Novel combination and use | |
| SI3233105T1 (sl) | Nove kombinacije in uporaba | |
| IL282508A (en) | Variants of protoxin-II and methods of use | |
| ZA201704105B (en) | Refractories and use thereof | |
| ZA201703976B (en) | Dihydropyrimidine-2-one compounds and medicinal uses thereof | |
| IL251335A0 (en) | Piperidinylpyrazolopyrimidinones and their use | |
| PT3397364T (pt) | Elementos estruturados e métodos de utilização | |
| AP2017009826A0 (en) | Stabilized adrenomedullin derivatives and use thereof | |
| GB201411196D0 (en) | Composition and use thereof | |
| GB201403697D0 (en) | Compounds and methods of use | |
| GB2545167B (en) | Cloches and use thereof | |
| PL3229772T3 (pl) | 6-arylo-9-glikozylopuryny i ich zastosowanie | |
| GB201404728D0 (en) | Disc-over incorporating disc-heads and disc-earning |